By Finance Pulse in KeyInfo —

Neumora Shares Dive as Depression Drug Fails Phase 3 Trial

Neumora Therapeutics shares nosedived after its promising depression drug failed in a crucial Phase 3 trial, impacting investor confidence. Learn more about the implications.

A graph depicting a sharp downward trend line on a stock chart, symbolizing the drop in Neumora Ther
Neumora Shares Dive as Depression Drug Fails Phase 3 Trial

Neumora Therapeutics shares plummeted after its depression drug failed in a Phase 3 trial.

Source